NuCana plc SEC filings NCNA
NuCana plc has 282 filings in SEC EDGAR's recent list, going back to Jun 26, 2017. Its latest annual report, Form 20-F, was filed on Mar 19, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Sep 30, 2026. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Jun 24, 2025 | — |
| CORRESP | Letter to the SEC | Jun 20, 2025 | — |
| UPLOAD | Letter from the SEC | Jun 13, 2025 | — |
| EFFECT | Filing | May 5, 2025 | — |
| EFFECT | Filing | May 5, 2025 | — |
| CORRESP | Letter to the SEC | May 5, 2025 | — |
| CORRESP | Letter to the SEC | May 5, 2025 | — |
| CORRESP | Letter to the SEC | May 1, 2025 | — |
| CORRESP | Letter to the SEC | May 1, 2025 | — |
| CORRESP | Letter to the SEC | Apr 29, 2025 | — |
| CORRESP | Letter to the SEC | Apr 29, 2025 | — |
| CORRESP | Letter to the SEC | Apr 29, 2025 | — |
| UPLOAD | Letter from the SEC | Apr 24, 2025 | — |
| DRSLTR | Filing | Apr 24, 2025 | — |
| UPLOAD | Letter from the SEC | Apr 17, 2025 | — |
| DRS | Filing | Apr 4, 2025 | — |
| UPLOAD | Letter from the SEC | Aug 19, 2024 | — |
| EFFECT | Filing | Aug 27, 2021 | — |
| CORRESP | Letter to the SEC | Aug 25, 2021 | — |
| UPLOAD | Letter from the SEC | Aug 25, 2021 | — |
| EFFECT | Filing | Oct 22, 2018 | — |
| CORRESP | Letter to the SEC | Oct 18, 2018 | — |
| UPLOAD | Letter from the SEC | Oct 10, 2018 | — |
| CT ORDER | Filing | Apr 19, 2018 | — |
| CT ORDER | Filing | Sep 28, 2017 | — |
| EFFECT | Filing | Sep 27, 2017 | — |
| EFFECT | Filing | Sep 27, 2017 | — |
| CERTNAS | Auto-generated paper document | Sep 25, 2017 | — |
| CORRESP | Letter to the SEC | Sep 25, 2017 | — |
| CORRESP | Letter to the SEC | Sep 25, 2017 | — |
| 8-A12B | Filing | Sep 22, 2017 | — |
| UPLOAD | Letter from the SEC | Sep 19, 2017 | — |
| CORRESP | Letter to the SEC | Sep 12, 2017 | — |
| UPLOAD | Letter from the SEC | Sep 12, 2017 | — |
| CORRESP | Letter to the SEC | Sep 6, 2017 | — |
| UPLOAD | Letter from the SEC | Aug 17, 2017 | — |
| DRSLTR | Filing | Aug 4, 2017 | — |
| DRS/A | Filing | Aug 4, 2017 | — |
| UPLOAD | Letter from the SEC | Jul 25, 2017 | — |
| DRS | Filing | Jun 26, 2017 | — |
Showing 40 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- NCNA (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- United Kingdom
- Headquarters
- Edinburgh, United Kingdom
- SEC filer status
- Non-accelerated filer
- SEC CIK
- 1709626
- Former names
- NuCana BioMed Ltd (until Aug 4, 2017)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.